We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$3.01B
AUM Growth
-$77.5M
Cap. Flow
-$45.6M
Cap. Flow %
-1.52%
Top 10 Hldgs %
32.99%
Holding
119
New
6
Increased
40
Reduced
57
Closed
7

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$28.4M
2
TDY icon
Teledyne Technologies
TDY
+$17.1M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$14.5M
4
IQV icon
IQVIA
IQV
+$13.6M
5
R icon
Ryder
R
+$12M

Sector Composition

Rank Sector Weight
1 Technology 30.15%
2 Financials 13.03%
3 Communication Services 10.89%
4 Industrials 10.55%
5 Healthcare 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
51
Amphenol
APH
$194B
$24M 0.8%
189,972
-18,704
-9% -$2.63M
NUE icon
52
Nucor
NUE
$54.9B
$23.7M 0.79%
139,948
-1,314
-0.9% -$229K
FWONK icon
53
Liberty Media Series C
FWONK
$24.2B
$23.5M 0.78%
276,480
+14,039
+5% +$1.23M
NFLX icon
54
Netflix
NFLX
$287B
$23.1M 0.77%
240,101
+11,763
+5% +$1.04M
EHC icon
55
Encompass Health
EHC
$11B
$22.8M 0.76%
236,042
+13,549
+6% +$1.39M
CELH icon
56
Celsius Holdings
CELH
$6.95B
$22.8M 0.76%
643,465
+48,611
+8% +$2.3M
CRDO icon
57
Credo Technology Group
CRDO
$44.1B
$22.8M 0.76%
242,422
-1,453
-0.6% -$177K
COST icon
58
Costco
COST
$411B
$22.6M 0.75%
22,643
+143
+0.6% +$139K
TXRH icon
59
Texas Roadhouse
TXRH
$12.5B
$22.1M 0.74%
133,889
+4,050
+3% +$727K
AXP icon
60
American Express
AXP
$233B
$21.8M 0.73%
72,134
-135
-0.2% -$45.3K
ACGL icon
61
Arch Capital
ACGL
$35B
$21.8M 0.72%
226,606
-428
-0.2% -$41K
LTH icon
62
Life Time Group Holdings
LTH
$9.33B
$21.7M 0.72%
806,455
-2,265
-0.3% -$62.6K
OLLI icon
63
Ollie's Bargain Outlet
OLLI
$3.94B
$21.1M 0.7%
229,108
-4,505
-2% -$486K
AEE icon
64
Ameren
AEE
$31.3B
$20.8M 0.69%
189,229
+473
+0.3% +$50.6K
PG icon
65
Procter & Gamble
PG
$342B
$20.3M 0.68%
140,737
+6,987
+5% +$1.06M
HD icon
66
Home Depot
HD
$324B
$20.3M 0.67%
61,577
+2,587
+4% +$943K
CL icon
67
Colgate-Palmolive
CL
$72.1B
$20.1M 0.67%
235,865
+12,075
+5% +$1.08M
POST icon
68
Post Holdings
POST
$4.09B
$19.8M 0.66%
200,398
+10,551
+6% +$1.07M
VOO icon
69
Vanguard S&P 500 ETF
VOO
$967B
$19.8M 0.66%
33,141
-610
-2% -$381K
PANW icon
70
Palo Alto Networks
PANW
$265B
$18.8M 0.62%
117,088
-4,798
-4% -$806K
TECK icon
71
Teck Resources
TECK
$29.3B
$18.4M 0.61%
355,317
-1,603
-0.4% -$85.8K
ABBV icon
72
AbbVie
ABBV
$454B
$18.3M 0.61%
84,259
+1,471
+2% +$326K
URBN icon
73
Urban Outfitters
URBN
$5.96B
$16.8M 0.56%
265,442
+8,116
+3% +$557K
TDY icon
74
Teledyne Technologies
TDY
$30.2B
$16.6M 0.55%
+27,433
New +$17.1M
LIN icon
75
Linde
LIN
$234B
$16.4M 0.54%
33,007
+2,202
+7% +$1.04M

Similar funds

Braun Stacey Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Braun Stacey Associates held 119 positions worth $3.01B, down 2.5% from $3.09B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Braun Stacey Associates's Q1 2026 filing shows 6 new, 40 increased, 57 reduced and 7 closed positions. Its largest new stake was Merck: 246,022 shares worth $29.6M. The largest sale was Neurocrine Biosciences, an estimated $25.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q1 2026 buy was Merck: 246,022 shares worth $29.6M.
  • Braun Stacey Associates added most to Ascendis Pharma A/S in Q1 2026, an estimated $2.67M increase.
  • Braun Stacey Associates's biggest Q1 2026 reduction was Boston Scientific, cutting an estimated $12.1M.
  • Braun Stacey Associates fully exited Neurocrine Biosciences in Q1 2026, selling an estimated $25.9M.
  • Braun Stacey Associates's ten largest holdings make up 33% of its $3.01B portfolio in Q1 2026.
  • Braun Stacey Associates opened 6 new positions and closed 7 in Q1 2026.
  • Braun Stacey Associates's portfolio value fell 2.5% quarter-over-quarter to $3.01B.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.